Cargando…
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
The translation of chimeric antigen receptor (CAR) T cell therapy for pediatric solid tumors is limited by the lack of preclinical models that fully recapitulate solid tumor biology. We describe steps to implement neuroblastoma metastatic and orthotopic mouse models. We delineate an analysis pipelin...
Autores principales: | Li, Nan, Nguyen, Rosa, Thiele, Carol J., Ho, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603305/ https://www.ncbi.nlm.nih.gov/pubmed/34825213 http://dx.doi.org/10.1016/j.xpro.2021.100942 |
Ejemplares similares
-
Generation of hypoxia-sensing chimeric antigen receptor T cells
por: Kosti, Paris, et al.
Publicado: (2021) -
Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma
por: Sawaisorn, Piamsiri, et al.
Publicado: (2020) -
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
por: Sun, Ming, et al.
Publicado: (2023) -
Human V(H)-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC
por: Kolluri, Aarti, et al.
Publicado: (2023) -
Genetic engineering of human and mouse CD4(+) and CD8(+) Tregs using lentiviral vectors encoding chimeric antigen receptors
por: Vimond, Nadège, et al.
Publicado: (2020)